Screener / SEC EDGAR /CIK 0001585364 /10-K filed Feb 26, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

PERRIGO Co plc PRGO

Compare with peers Embed
Why it changed

The biggest changes in the 10-K filed Feb 26, 2026, in management's words

10-K, Item 7

This fiscal year against the last, and the sentences in the MD&A where management explains each change. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.

Operating margin

Big change, FY to Dec 31, 2025 vs Dec 31, 2024

2.6% to -26.4% (-29.0 pts)

“Operating income decreased $1,235.1 million, or 1,094.0%, due to:”

Read it in the 10-K

“$1,186.9 million increase in operating expenses driven by the $1.3 billion goodwill impairment charge.”

Read it in the 10-K

Cash from operations

Big change, FY to Dec 31, 2025 vs Dec 31, 2024

-34.3%

The MD&A has no sentence that names a cause for this change.

Revenue

Change, FY to Dec 31, 2025 vs Dec 31, 2024

-2.8%

“Net sales decreased $120.3 million, or 2.8%, primarily due to:”

Read it in the 10-K

“Net sales decreased $108.4 million, or 4.0% primarily due to:”

Read it in the 10-K

Gross margin

Change, FY to Dec 31, 2025 vs Dec 31, 2024

35.3% to 35.1% (-0.1 pts)

“$48.2 million decrease in gross profit due primarily to lower global OTC sales volumes, the impact of divested businesses and exited products of $41.6 million, and net impact of pricing actions.”

Read it in the 10-K

“Gross profit as a percentage of net sales decreased 20 basis points compared to the prior year due to the same factors that impacted gross profit; and”

Read it in the 10-K

What management said, year by year

The cause given in each 10-K, 2 fiscal years, newest first · MD&A (Item 7)

Each bar is how the line changed that year (from the same 10-K's XBRL). Under it, the sentence in that year's MD&A that names the line, a direction and a cause, word for word. A year with no sentence says so.

Revenue

2 of 2 years explained

Gross margin

2 of 2 years explained
  • FY 2025 -0.1 pts

    “$48.2 million decrease in gross profit due primarily to lower global OTC sales volumes, the impact of divested businesses and exited products of $41.6 million, and net impact of pricing actions.”

    Read it in the FY 2025 10-K

    “Gross profit as a percentage of net sales decreased 20 basis points compared to the prior year due to the same factors that impacted gross profit; and”

    Read it in the FY 2025 10-K
  • FY 2024 -0.8 pts

    “$137.7 million decrease in gross profit driven by the impact of lower global OTC net sales volumes resulting from a focus on production of higher margin products, including positive impacts from $57.1 million of new products, and lower infant formula volumes within U.S.”

    Read it in the FY 2024 10-K

    “Gross profit as a percentage of net sales decreased 80 basis points compared to the prior year due to the same factors that impacted gross profit; and”

    Read it in the FY 2024 10-K

Operating margin

2 of 2 years explained

Cash from operations

0 of 2 years explained
  • FY 2025 -34.3%

    The FY 2025 MD&A has no sentence that names a cause for this change.

  • FY 2024 -10.5%

    The FY 2024 MD&A has no sentence that names a cause for this change.

Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K

Sources

The Management's Discussion and Analysis (Item 7) of the latest 10-K, quoted word for word; the changes are computed from the same 10-K's XBRL.

Also

Financials: the numbers year by year.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PRGO/export.csv") into a cell.

Next:Accounting checks
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.